| Property | Value |
|---|
| Working Groups |  Lingor |
| Subproject | None |
| Open Access |  Yes |
| Publication Type | Clinical Study |
| Peer Reviewed | Yes |
| PMID |  30972018 |
| DOI |  10.3389/fneur.2019.00293 |
| Publication Year | 2019 |
| Title | ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis.  |
| Journal | Frontiers in neurology |
| ISSN | 1664-2295 |
| ESSN | 1664-2295 |
| URL | https://www.ncbi.nlm.nih.gov/pubmed/?term=30972018%5Buid%5D |
| Pages | 293 |
| Volume | 10 |
| Journal Abbreviation | Front Neurol |
| Authors | Lingor P, Weber M, Camu W, Friede T, Hilgers R, Leha A, Neuwirth C, Günther R, Benatar M, Kuzma-Kozakiewicz M, Bidner H, Blankenstein C, Frontini R, Ludolph A, Koch JC |
| First Author | Lingor P |
| Last Author | Koch JC |
| Scholia |  Wikidata-based representation at Scholia |
External Resources
Q64111651https://www.wikidata.org/wiki/Q64111651
Wikidata ID
